International Isotopes (INIS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : International Isotopes (INIS)

INIS 0.0660

-2.9%

Dec 10 11:09 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RRICH4 who wrote (11)	3/1/1998 12:09:00 AM
From: BDR	of 81

<<The radioisotope in therapeutic doses can be 10 to 100 times as high as in diagnostics. This implies there will be explosive demand for the more esoteric isotopes that ONLY THE COMPANY'S LINAC CAN MAKE IN QUANTITY.>> Could you explain what you mean by this? Higher dosage means more isotope means more revenue? Only if there is more demand for the therapeutic use of the isotopes, which will depend on finding delivery vehicles for the isotopes specific enough to target the diseased cells.Am I correct? I don't think it is availability of isotopes that is holding back their use, though lowering the cost will increase demand. Will INIS become the low cost provider in this field of isotopes that could be packaged by other companies (e.g. THRX) or are they going to directly market the end product?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next